Advertisement

Army turning to AI in its fight against biological threats

Senior military and defense officials shared new details with reporters about the Army’s new biodefense strategy.
Listen to this article
0:00
Learn more. This feature uses an automated voice, which may result in occasional errors in pronunciation, tone, or sentiment.
A laboratory technician at the Synthetic Biology and Biosurveillance Branch at the U.S. Army Medical Research Institute of Infectious Diseases demonstrates the Biodefense Mass Sequencing and Surveillance assay, developed by a team of researchers under the direction of branch chief Lt. Col. Jeffrey Kugelman during the coronavirus pandemic as a way to rapidly test large numbers of Service Members for exposure to COVID-19. BMASS can be used to test for multiple diseases at the same time, extending its potential beyond just COVID-19 surveillance. (DOD photo by: Paul Lagasse)

The Army is moving to combine environmental, clinical, logistics, chemical, biological and intelligence data with artificial intelligence to identify unseen and emerging disease outbreaks before they can spread widely or harm the force. 

Senior officials who developed the 2026 Army Biodefense Strategy discussed their new approach to operationalizing security measures against biological threats during a media roundtable Monday at the annual AUSA conference.

“There’s a lot of data involved in doing bio-surveillance and sort of figuring out when that threat rears its head early enough to do something about it. And so, we are looking very heavily toward how we leverage AI to help us integrate and sort through that data,” Dr. Alison Tamasi told DefenseScoop.

Tamasi serves as chief of the Survivability and Effects Analysis Division at the U.S. Army Nuclear and Countering Weapons of Mass Destruction Agency. 

Advertisement

She noted that, compared to the prior biodefense strategy released in 2021, this new plan marks “a big pivot” for the service in that it transforms biodefense from a more localized medical or chemical specialty into an integrated, “whole-of-Army” operational priority. 

“We are confronting a volatile technological convergence where advanced biotechnology and artificial intelligence are dramatically lowering the barrier to engineering biological weapons. Our adversaries view these agents as tools to degrade our logistics, paralyze our mobilization and deployment, and erode our combat power. This is a strategic threat to our nation’s ability to respond to a crisis,” former Army Secretary Dan Driscoll wrote in the document’s foreword.

At the roundtable, the senior officials emphasized that the Army is taking steps to ensure that its own strategy can be quickly and fully integrated with the overarching approach that the Defense Department is taking towards biological surveillance and defense. 

They suggested that the Office of the Secretary of Defense has an “imminent biodeterrent posture that will come out” in the future. 

“The Army is sort of the first service that came out ahead and led the way on having a Biodefense Strategy, but that doesn’t mean that we’re doing anything in a vacuum,” Tamasi said. 

Advertisement

Lt. Col. David Kingery, who led the strategy’s development as the Army’s senior biodefense advisor, added that coordination with the rest of the services and the department is “extremely important” to ensure that authorities are met and data systems are interoperable.

“There is an effort to pull the multiple different data streams and use AI [and machine learning for] predictive analysis to help us speed the early analysis, always using [a human] in the loop,” Kingery told DefenseScoop.

Heaps of data sources — from environmental monitoring, compliant medical and clinical information, intelligence resources and more — will be integrated to support biodefense work.   

“We recognize that all of the wonderful things that are happening in AI to accelerate biomedicine are dual-use problems, and so we are very much doing it from that lens of the fact that the threat could change very rapidly in the biomedicine space,” Tamasi said.

She told DefenseScoop that there is not an offensive angle to the Army’s strategy.

Brandi Vincent

Written by Brandi Vincent

Brandi Vincent is a Senior Reporter at DefenseScoop, where she reports on disruptive technologies and associated policies impacting Pentagon and military personnel. Prior to joining SNG, she produced a documentary and worked as a journalist at Nextgov, Snapchat and NBC Network. Brandi grew up in Louisiana and received a master’s degree in journalism from the University of Maryland. She was named Best New Journalist at the 2024 Defence Media Awards.

Latest Podcasts